CURX vs T · $8.9M cap vs P/E 7.4, rev $63.06B
Curanex Pharmaceuticals Inc Common Stock (CURX) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
CURX does not have a complete income-statement cache yet.
Latest reported T revenue for 2026-06-30 was $63.06B. Net income was $8.46B. T currently screens at market cap $155.92B and trailing P/E 7.4.
CURX currently screens at market cap $8.9M. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the CURX and T stock pages for the full models.
Not investment advice.